BidaskClub Downgrades Simulations Plus (NASDAQ:SLP) to Hold

BidaskClub cut shares of Simulations Plus (NASDAQ:SLP) from a buy rating to a hold rating in a research report sent to investors on Thursday, April 11th, BidAskClub reports.

Several other research analysts have also recently weighed in on the stock. Zacks Investment Research upgraded shares of Simulations Plus from a sell rating to a hold rating in a research note on Wednesday, March 20th. Taglich Brothers cut shares of Simulations Plus from a buy rating to a speculative buy rating in a research note on Wednesday, January 16th.

SLP stock traded up $0.86 on Thursday, hitting $23.19. The company had a trading volume of 37,747 shares, compared to its average volume of 50,297. The stock has a market capitalization of $406.17 million, a P/E ratio of 46.38 and a beta of -0.47. Simulations Plus has a 12-month low of $16.70 and a 12-month high of $23.95.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Tuesday, April 9th. The technology company reported $0.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.10 by $0.02. The business had revenue of $8.47 million for the quarter, compared to analysts’ expectations of $8.10 million. Simulations Plus had a net margin of 23.61% and a return on equity of 22.87%. On average, analysts predict that Simulations Plus will post 0.43 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 1st. Investors of record on Wednesday, April 24th were paid a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend was Tuesday, April 23rd. Simulations Plus’s dividend payout ratio (DPR) is 48.00%.

In other Simulations Plus news, Director David L. Ralph sold 3,000 shares of Simulations Plus stock in a transaction on Friday, April 12th. The shares were sold at an average price of $22.74, for a total value of $68,220.00. Following the sale, the director now directly owns 18,006 shares in the company, valued at approximately $409,456.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Walter S. Woltosz sold 18,500 shares of Simulations Plus stock in a transaction on Wednesday, March 27th. The shares were sold at an average price of $20.64, for a total transaction of $381,840.00. Following the completion of the sale, the insider now owns 5,214,539 shares in the company, valued at $107,628,084.96. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 58,500 shares of company stock worth $1,241,120. 31.57% of the stock is owned by corporate insiders.

Several institutional investors have recently bought and sold shares of SLP. Wedge Capital Management L L P NC lifted its holdings in Simulations Plus by 16.5% during the first quarter. Wedge Capital Management L L P NC now owns 51,311 shares of the technology company’s stock valued at $1,083,000 after purchasing an additional 7,265 shares in the last quarter. BNP Paribas Arbitrage SA lifted its holdings in Simulations Plus by 59,875.0% during the first quarter. BNP Paribas Arbitrage SA now owns 2,399 shares of the technology company’s stock valued at $51,000 after purchasing an additional 2,395 shares in the last quarter. Redmond Asset Management LLC lifted its holdings in Simulations Plus by 1.8% during the first quarter. Redmond Asset Management LLC now owns 29,076 shares of the technology company’s stock valued at $614,000 after purchasing an additional 515 shares in the last quarter. Conestoga Capital Advisors LLC purchased a new position in Simulations Plus during the first quarter valued at $320,000. Finally, Geode Capital Management LLC lifted its holdings in Simulations Plus by 6.5% during the fourth quarter. Geode Capital Management LLC now owns 128,181 shares of the technology company’s stock valued at $2,550,000 after purchasing an additional 7,794 shares in the last quarter. Hedge funds and other institutional investors own 40.72% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.

Read More: Trading Stocks – What are percentage gainers?

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.